Logo image of ACLS

AXCELIS TECHNOLOGIES INC (ACLS) Stock Fundamental Analysis

USA - NASDAQ:ACLS - US0545402085 - Common Stock

81.54 USD
-1.08 (-1.31%)
Last: 11/14/2025, 8:00:00 PM
81.54 USD
0 (0%)
After Hours: 11/14/2025, 8:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ACLS. ACLS was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ACLS has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

ACLS had positive earnings in the past year.
ACLS had a positive operating cash flow in the past year.
Each year in the past 5 years ACLS has been profitable.
ACLS had a positive operating cash flow in each of the past 5 years.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

ACLS has a better Return On Assets (10.05%) than 79.46% of its industry peers.
ACLS's Return On Equity of 13.32% is fine compared to the rest of the industry. ACLS outperforms 78.57% of its industry peers.
The Return On Invested Capital of ACLS (10.49%) is better than 81.25% of its industry peers.
ACLS had an Average Return On Invested Capital over the past 3 years of 21.34%. This is significantly above the industry average of 10.93%.
The last Return On Invested Capital (10.49%) for ACLS is well below the 3 year average (21.34%), which needs to be investigated, but indicates that ACLS had better years and this may not be a problem.
Industry RankSector Rank
ROA 10.05%
ROE 13.32%
ROIC 10.49%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ACLS's Profit Margin of 15.93% is fine compared to the rest of the industry. ACLS outperforms 76.79% of its industry peers.
ACLS's Profit Margin has improved in the last couple of years.
ACLS's Operating Margin of 16.14% is fine compared to the rest of the industry. ACLS outperforms 75.89% of its industry peers.
ACLS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 44.68%, ACLS is in line with its industry, outperforming 51.79% of the companies in the same industry.
ACLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.14%
PM (TTM) 15.93%
GM 44.68%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

ACLS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for ACLS has been reduced compared to 1 year ago.
Compared to 5 years ago, ACLS has less shares outstanding
The debt/assets ratio for ACLS has been reduced compared to a year ago.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ACLS has an Altman-Z score of 6.74. This indicates that ACLS is financially healthy and has little risk of bankruptcy at the moment.
ACLS's Altman-Z score of 6.74 is fine compared to the rest of the industry. ACLS outperforms 66.07% of its industry peers.
The Debt to FCF ratio of ACLS is 0.34, which is an excellent value as it means it would take ACLS, only 0.34 years of fcf income to pay off all of its debts.
ACLS's Debt to FCF ratio of 0.34 is amongst the best of the industry. ACLS outperforms 82.14% of its industry peers.
ACLS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.04, ACLS is doing good in the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.34
Altman-Z 6.74
ROIC/WACC0.97
WACC10.85%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.95 indicates that ACLS has no problem at all paying its short term obligations.
ACLS's Current ratio of 4.95 is fine compared to the rest of the industry. ACLS outperforms 73.21% of its industry peers.
A Quick Ratio of 3.32 indicates that ACLS has no problem at all paying its short term obligations.
The Quick ratio of ACLS (3.32) is better than 65.18% of its industry peers.
Industry RankSector Rank
Current Ratio 4.95
Quick Ratio 3.32
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

ACLS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.22%.
Measured over the past years, ACLS shows a very strong growth in Earnings Per Share. The EPS has been growing by 64.54% on average per year.
Looking at the last year, ACLS shows a very negative growth in Revenue. The Revenue has decreased by -20.69% in the last year.
Measured over the past years, ACLS shows a very strong growth in Revenue. The Revenue has been growing by 24.30% on average per year.
EPS 1Y (TTM)-27.22%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-18.79%
Revenue 1Y (TTM)-20.69%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-16.74%

3.2 Future

Based on estimates for the next years, ACLS will show a decrease in Earnings Per Share. The EPS will decrease by -6.87% on average per year.
Based on estimates for the next years, ACLS will show a decrease in Revenue. The Revenue will decrease by -4.79% on average per year.
EPS Next Y-31.47%
EPS Next 2Y-16.58%
EPS Next 3Y-6.87%
EPS Next 5YN/A
Revenue Next Year-22.15%
Revenue Next 2Y-9.36%
Revenue Next 3Y-4.79%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.57, which indicates a correct valuation of ACLS.
ACLS's Price/Earnings ratio is rather cheap when compared to the industry. ACLS is cheaper than 91.07% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.89, ACLS is valued a bit cheaper.
A Price/Forward Earnings ratio of 19.05 indicates a rather expensive valuation of ACLS.
80.36% of the companies in the same industry are more expensive than ACLS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, ACLS is valued a bit cheaper.
Industry RankSector Rank
PE 16.57
Fwd PE 19.05
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACLS is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ACLS is valued cheaply inside the industry as 84.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.38
EV/EBITDA 11.98
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

ACLS has an outstanding profitability rating, which may justify a higher PE ratio.
ACLS's earnings are expected to decrease with -6.87% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.26
EPS Next 2Y-16.58%
EPS Next 3Y-6.87%

0

5. Dividend

5.1 Amount

No dividends for ACLS!.
Industry RankSector Rank
Dividend Yield N/A

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (11/14/2025, 8:00:00 PM)

After market: 81.54 0 (0%)

81.54

-1.08 (-1.31%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-09 2026-02-09/amc
Inst Owners105.9%
Inst Owner Change0.55%
Ins Owners0.96%
Ins Owner Change9.53%
Market Cap2.53B
Revenue(TTM)853.13M
Net Income(TTM)135.90M
Analysts72.86
Price Target107.03 (31.26%)
Short Float %14.68%
Short Ratio7.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.02%
Min EPS beat(2)18.27%
Max EPS beat(2)51.76%
EPS beat(4)4
Avg EPS beat(4)63.7%
Min EPS beat(4)18.27%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)37.07%
EPS beat(12)12
Avg EPS beat(12)30.57%
EPS beat(16)16
Avg EPS beat(16)28.34%
Revenue beat(2)2
Avg Revenue beat(2)3.85%
Min Revenue beat(2)3.02%
Max Revenue beat(2)4.69%
Revenue beat(4)4
Avg Revenue beat(4)2.71%
Min Revenue beat(4)1.02%
Max Revenue beat(4)4.69%
Revenue beat(8)7
Avg Revenue beat(8)1.76%
Revenue beat(12)11
Avg Revenue beat(12)2.45%
Revenue beat(16)15
Avg Revenue beat(16)2.56%
PT rev (1m)7.82%
PT rev (3m)20.45%
EPS NQ rev (1m)17%
EPS NQ rev (3m)17.42%
EPS NY rev (1m)0%
EPS NY rev (3m)25.47%
Revenue NQ rev (1m)6.71%
Revenue NQ rev (3m)6.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.31%
Valuation
Industry RankSector Rank
PE 16.57
Fwd PE 19.05
P/S 2.96
P/FCF 20.38
P/OCF 18.36
P/B 2.48
P/tB 2.48
EV/EBITDA 11.98
EPS(TTM)4.92
EY6.03%
EPS(NY)4.28
Fwd EY5.25%
FCF(TTM)4
FCFY4.91%
OCF(TTM)4.44
OCFY5.45%
SpS27.52
BVpS32.91
TBVpS32.91
PEG (NY)N/A
PEG (5Y)0.26
Graham Number60.36
Profitability
Industry RankSector Rank
ROA 10.05%
ROE 13.32%
ROCE 11.94%
ROIC 10.49%
ROICexc 17.19%
ROICexgc 17.19%
OM 16.14%
PM (TTM) 15.93%
GM 44.68%
FCFM 14.54%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ROICexc(3y)45.35%
ROICexc(5y)37.49%
ROICexgc(3y)45.35%
ROICexgc(5y)37.49%
ROCE(3y)24.29%
ROCE(5y)20.95%
ROICexgc growth 3Y-3.61%
ROICexgc growth 5Y39%
ROICexc growth 3Y-3.61%
ROICexc growth 5Y39%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
F-Score7
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.34
Debt/EBITDA 0.27
Cap/Depr 78.18%
Cap/Sales 1.6%
Interest Coverage 250
Cash Conversion 88.75%
Profit Quality 91.27%
Current Ratio 4.95
Quick Ratio 3.32
Altman-Z 6.74
F-Score7
WACC10.85%
ROIC/WACC0.97
Cap/Depr(3y)109.12%
Cap/Depr(5y)96.53%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.41%
Profit Quality(3y)77.07%
Profit Quality(5y)99.84%
High Growth Momentum
Growth
EPS 1Y (TTM)-27.22%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-18.79%
EPS Next Y-31.47%
EPS Next 2Y-16.58%
EPS Next 3Y-6.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.69%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-16.74%
Revenue Next Year-22.15%
Revenue Next 2Y-9.36%
Revenue Next 3Y-4.79%
Revenue Next 5YN/A
EBIT growth 1Y-41.65%
EBIT growth 3Y18.31%
EBIT growth 5Y54.17%
EBIT Next Year-33.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.8%
FCF growth 3Y-3.13%
FCF growth 5YN/A
OCF growth 1Y-35.59%
OCF growth 3Y-2.13%
OCF growth 5YN/A

AXCELIS TECHNOLOGIES INC / ACLS FAQ

Can you provide the ChartMill fundamental rating for AXCELIS TECHNOLOGIES INC?

ChartMill assigns a fundamental rating of 6 / 10 to ACLS.


What is the valuation status for ACLS stock?

ChartMill assigns a valuation rating of 6 / 10 to AXCELIS TECHNOLOGIES INC (ACLS). This can be considered as Fairly Valued.


What is the profitability of ACLS stock?

AXCELIS TECHNOLOGIES INC (ACLS) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for ACLS stock?

The Price/Earnings (PE) ratio for AXCELIS TECHNOLOGIES INC (ACLS) is 16.57 and the Price/Book (PB) ratio is 2.48.


Can you provide the financial health for ACLS stock?

The financial health rating of AXCELIS TECHNOLOGIES INC (ACLS) is 9 / 10.